The purpose of this study is to assess how PPI treated GERD patients with insufficient
symptom control will benefit from a change in management by providing a more efficient acid
secretion inhibition during 4 weeks, by evaluation of esomeprazole 40 mg compared to
pre-study PPI treatment.